Ignite Creation Date:
2024-05-06 @ 1:04 AM
Last Modification Date:
2024-10-26 @ 10:58 AM
Study NCT ID:
NCT01722175
Status:
WITHDRAWN
Last Update Posted:
2014-07-22
First Post:
2012-11-02
Brief Title:
Associating Liver Partition With Portal Vein Ligation For Staged Hepatectomy ALPPS or Portal Vein Occlusion in Treating Patients With Liver Cancer
Sponsor:
Washington University School of Medicine
Organization:
Washington University School of Medicine
Study Overview
Official Title:
Associating Liver Partition With Portal Vein Ligation for Staged Hepatectomy ALPPS Versus Portal Vein Occlusion PVO to Induce Liver Regeneration for Resection of Liver Tumors That Are Unresectable in One Step - a Randomized Controlled Trial
Status:
WITHDRAWN
Status Verified Date:
2014-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Safety concerns
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ALPPS
Brief Summary:
This randomized phase II trial compares how well associating liver partition with portal vein ligation for staged hepatectomy ALPPS or portal vein occlusion PVO works in treating patients with liver cancer Both treatments are types of 2-stage hepatectomies for removing liver cancer ALPPS may be more effective than PVO in patients whose disease would traditionally be considered inoperable
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None